Tag: Pfizer

Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is among the world’s largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology.

Bavencio, Inlyta Combo Granted Early Access to Medicines status by MHRA

Merck and Pfizer have announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for Bavencio (a...

ViiV Healthcare Launch Study for First-Ever Long-Acting Injectable Therapy for HIV

viiv healthcare
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the start of the CUSTOMIZE trial (Cabotegravir plus Ril...

Pfizer Announced Updated Results from Study Evaluating SB-525 Gene Therapy for Hemophilia A

Sangamo Therapeutics, Inc., a genomic medicine company, and Pfizer, Inc. announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A....

Pfizer Completed Acquisition of Biotechnology Company Therachon Holding AG

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction, Pfizer acquired ...

Pfizer Received FDA Approval for Avastin® Biosimilar

Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved ZIRABEV™ (bevacizumab-bvzr), a biosimilar to Avastin® (bevacizumab), for the treatment of five type...

Scott Gottlieb Joins Pfizer’s Board of Directors

Pfizer Inc. announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the S...

Pfizer UK Recalled Docetaxel Injection 160mg and Docetaxel Injection 20mg

Pfizer
Pfizer UK Limited is recalling batches as routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life. CLDA Number...

Pfizer to Acquire Biopharmaceutical Company Array BioPharma

Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on ...

Pfizer Opened New R&D Facility in Missouri

Building on our 17-year history in Missouri, a newly opened, state-of-the-art, 295,000 square feet facility in Chesterfield will expand the capacity of colleagues dedicated to the research and develop...

Pfizer’s Fragmin Granted FDA Approval

The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric pati...

FDA Approved Bavencio for Treatment of Patients with Advanced Renal Cell Carcinoma

cancer-drugs
Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of patients with advanced ren...

Pfizer Selected First Drug Candidate From Pfizer-Sosei Alliance

Pfizer has selected the first drug candidate from a collaboration with Sosei Group to develop drugs for major diseases, which are aimed at targets from the G protein-coupled receptor (GPCR) class. ...

Pfizer Opened New Manufacturing Facility in USA

Pfizer Inc. announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Mass. Pfizer’s Andover site houses commercial manufacturing and product development functions, with co...

Pfizer Agreed to Acquire Clinical-Stage Biotech Therachon

pfizer
Pfizer today announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare diseases...

EС Approved Pfizer’s LORVIQUA®

Pfizer Inc. announced today that the European Commission (EC) granted conditional marketing authorization for LORVIQUA® (lorlatinib, available in the U.S., Canada and Japan under the brand name LORBRE...

Pfizer Received FDA Approval for ATTR-CM Drug

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved both VYNDAQEL® (tafamidis meglumine) and VYNDAMAX™ (tafamidis) for the treatment of the cardiomyopathy of wild-type ...